VP, US Field Medical Oncology Commercialization at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

MD, PhD or PharmD with 15+ years of experience working in Medical, development or clinical roles in the biotech or pharmaceutical industries
Hematology / Oncology scientific expertise
Ability to think medically & strategically about short term and long-term impacts with US healthcare landscape
Familiarity with all phases of drug development, including clinical development, regulatory and life cycle management
Proven impact and influence with key thought leaders (TLs)
Strong leadership skills to lead and contribute to the overall strategic planning and execution of key deliverables for the division
Sound understanding of industry trends, strategic planning, analytical thinking, negotiation, presentation, written and verbal communication, and relationship-building skills
Proven track record of effectively and efficiently driving performance and communication

Responsibilities

Leads development of field medical plan that is both product specific & disease-area focused and in appropriate alignment with Hematology / Oncology, translating appropriate strategies into effective US Medical launch and life cycle management activities
Active leadership and participation as core member on the US Hematology / Oncology leadership team and closely collaborating and partnering with worldwide counterparts to craft the HOM plan that ensures US market needs are addressed
Transparent communication and close collaboration with US Access (HEOR) organizations to integrate medical perspectives into the commercialization process and ensure appropriate alignment between commercial and medical
Externally focused and connected to high impact external influencers to identify & translate key insights
Leadership of TA aligned field-facing resources that provide them with the necessary coaching to ensure customer objectives are met
Work in close collaboration with home office medical to ensure the field team is equipped with the highest quality resources to execute their strategy
Contributes to shaping the competitive strategies around pricing and reimbursement by influencing a US perspective for the target product profile, label language and value considerations
Continually measure and assess the effectiveness of US medical plans
Maintain clinical, scientific & technical expertise in Hematology / Oncology
Ensures all strategies, plans and tactics are in line with legal and compliance requirement
Ability to lead and develop an organization with strength in medical and scientific expertise and promoted collaborative alignment between field and home office staff
In partnership with US and WW Commercialization, shape, communicate, and execute field medical strategies that promote access to our products through clear demonstration of value
Strong external customer focus and the ability to rapidly build a comprehensive and efficient network of external relationships
Fosters an inclusive, high-performance culture, by empowering and energizing a diverse workforce

Skills

Oncology

Hematology

Medical Affairs

Field Medical

Commercialization

HEOR

Leadership

Strategic Planning

Stakeholder Engagement

Cross-functional Collaboration

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free